PDL BioPharma (PDLI): Q2 EPS of $0.52 beats by $0.08. Revenue of $12.9M (+3.1% Y/Y) in-line....

|About: PDL BioPharma, Inc. (PDLI)|By:, SA News Editor
PDL BioPharma (PDLI): Q2 EPS of $0.52 beats by $0.08. Revenue of $12.9M (+3.1% Y/Y) in-line. Shares +1.1% AH. (PR)